Results 211 to 220 of about 3,066,996 (254)

Current recommendations and recent progress in endometrial cancer

Ca-A Cancer Journal for Clinicians, 2019
Gini F Fleming
exaly  

Designer drugs.

Texas medicine, 1989
Designer drugs are synthetic analogs of substances with known psychoactive properties. These analogs are dangerous due to their direct pharmacological effects and the presence of toxic by-products that occur during synthesis. Three groups of designer drugs are reviewed (fentanyl, meperidine, and methamphetamine analogs), and their psychoactive effects ...
openaire   +1 more source

Recent progress in pancreatic cancer

Ca-A Cancer Journal for Clinicians, 2013
Christopher L Wolfgang, Daniel A Laheru, Elliot Fishman   +2 more
exaly  

Hodgkin lymphoma: A review and update on recent progress

Ca-A Cancer Journal for Clinicians, 2018
Satish P Shanbhag, Richard F Ambinder
exaly  

Immunotherapy of cancer in 2012

Ca-A Cancer Journal for Clinicians, 2012
Lisa H Butterfield, Ahmad A Tarhini
exaly  

Patient adherence and persistence with oral anticancer treatment

Ca-A Cancer Journal for Clinicians, 2009
Kathryn J Ruddy, Ann H Partridge
exaly  

Designer Drugs

Alcoholism Treatment Quarterly, 1988
openaire   +1 more source

Drug Design

2017
Christian Betzel, Arayik Martirosyan
openaire   +1 more source

Structure-Based Drug Design (Rational Drug Design)

2004
openaire   +1 more source

Drug Design

1980
openaire   +2 more sources